Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis L Pisters

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinicLydia T Madsen, Deborah A Kuban, Seungtaek Choi, et al.
BJU International|November 28, 2006
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?Gordon A Brown, J Erik Busby, Christopher G Wood, et al.
Urologic Oncology|February 22, 2015
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intentMegan M Merrill, Christopher G Wood, Nizar M Tannir, et al.
Cancers|March 10, 2022
Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and ImplicationsJoseph A Moore, Rebecca S Slack, Michael J Lehner, et al.
European Urology|September 12, 2008
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancerJohn W Davis, David W Chang, Pierre Chevray, et al.
Journal of Clinical Medicine|June 27, 2024
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable CancerJamaal C Jackson, Darren Sanchez, Andrew C Johns, et al.
Cells|May 13, 2025
Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of CancersJamaal C Jackson, Darren Sanchez, Aron Y Joon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancerJeri Kim, Peiyu Sun, Ying-Wai Lam, et al.
Urologic Oncology|October 1, 2015
Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center ExperiencePhilip L Ho, Daniel L Willis, Jeevitha Patil, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinicLydia T Madsen, Deborah A Kuban, Seungtaek Choi, et al.
BJU International|November 28, 2006
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?Gordon A Brown, J Erik Busby, Christopher G Wood, et al.
Urologic Oncology|February 22, 2015
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intentMegan M Merrill, Christopher G Wood, Nizar M Tannir, et al.
Cancers|March 10, 2022
Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and ImplicationsJoseph A Moore, Rebecca S Slack, Michael J Lehner, et al.
European Urology|September 12, 2008
Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancerJohn W Davis, David W Chang, Pierre Chevray, et al.
Journal of Clinical Medicine|June 27, 2024
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable CancerJamaal C Jackson, Darren Sanchez, Andrew C Johns, et al.
Cells|May 13, 2025
Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of CancersJamaal C Jackson, Darren Sanchez, Aron Y Joon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancerJeri Kim, Peiyu Sun, Ying-Wai Lam, et al.
Urologic Oncology|October 1, 2015
Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center ExperiencePhilip L Ho, Daniel L Willis, Jeevitha Patil, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
Pageof 17